# Dart Xia Yan Venture Capital

> Dart Xia Yan Venture Capital is a VC fund in Hangzhou backing Medical and Health Care. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Hangzhou, China
- Total investments: 4
- Last investment: Nov 2025
- Lead investor: 0%
- Last updated: Aug 2026

Dart Xia Yan Venture Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 50% |
| Health Care | 2 | 50% |
| Manufacturing | 2 | 50% |
| Pharmaceutical | 2 | 50% |
| Therapeutics | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 50% |
| Series A | 1 | 25% |
| Series B | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 2 | 50% |
| United Kingdom | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Coherence Neuro | Opto Biosystems specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics,Opto Biosystems is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector. Their work includes exploring the stability of thin-film electrodes for neuromodulation, highlighting their commitment to advancing medical technology. | $10M | Seed | Nov 03, 2025 |  |
| Juvensis Therapeutics | Juvensis Therapeutics is a gene therapy drug development company based on original mechanisms. | $13.8M | Seed | Mar 10, 2025 |  |
| Shengbao Bio | Shengbao Bio is committed to the development of novel live bacterial medications, leveraging gene circuits and precise regulation of gene and payload expression. |  | Series A | Jul 26, 2024 |  |
| Full-Life Technologies | Full-Life Technologies Limited (“Full-Life”) is a fully integrated global RadioTherapeutics company headquartered in Shanghai, China with operations in Europe. | $47.3M | Series B | Jan 03, 2024 |  |

4 of 4 investments shown.

## Co-investors
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund, 1 deal together
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund, 1 deal together
- [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund) — VC Fund, 1 deal together
- [Chengwei Capital](https://shizune.co/investors/profile/chengwei-capital) — VC Fund, 1 deal together
- [Divergent Capital](https://shizune.co/investors/profile/divergent-capital-1c5e) — VC Fund, 1 deal together
- [Fosun Health Capital](https://shizune.co/investors/profile/fosun-health-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Dart Xia Yan Venture Capital invest in?

Dart Xia Yan Venture Capital invests primarily in Medical, Health Care and Manufacturing startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dart Xia Yan Venture Capital last invest?

The most recent investment recorded for Dart Xia Yan Venture Capital closed in Nov 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co